| Vol. 10.29 – 5 August, 2021 |
| |
|
|
| Investigators characterized the proteogenomic landscape of lung squamous cell carcinoma (LSCC), providing a deeper exposition of LSCC biology with potential therapeutic implications. [Cell] |
| |
|
|
PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Researchers showed that the latent forms of TGFβ2 and TGFβ3 could be activated by integrin-independent mechanisms and have lower activation thresholds compared to TGFβ1. Unlike TGFB1, TGFB2 and TGFB3 expression was increased in human lung and liver fibrotic tissues compared to healthy control tissues. [Science Translational Medicine] |
|
|
|
| A549 lung epithelial cells transfected with Klotho cDNA or vector were exposed to cigarette smoke; lactate dehydrogenase and double-strand DNA breaks were measured. [American Journal of Physiology-Lung Cellular and Molecular Physiology] |
|
|
|
| Scientists demonstrated that fibroblast growth factor-binding protein 1 was dramatically upregulated in airway epithelial cell lines treated by poly-L-arginine, a mimic of major basic protein. [Cell Death & Disease] |
|
|
|
| Researchers analyzed sex-specific fetal distal lung epithelial cells exposed to epidermal growth factor and related ligands with Ussing chambers, RT-qPCR and Western blots. [Scientific Reports] |
| |
|
|
| Scientists showed that exon 2 inclusion in the U2AF2 mRNA was a cell cycle-dependent process that was regulated by LEDGF/SRSF1 splicing complexes, whose assembly was controlled by the IWS1 phosphorylation-dependent deposition of histone H3K36me3 marks in the body of target genes. [Nature Communications] |
|
|
|
| Researchers demonstrated that integrated stress response was pivotal in lung adenocarcinoma development, the most common histological type of lung cancer and a leading cause of cancer death worldwide. [Nature Communications] |
| | Investigators examined the potential roles of RAS-associated domain family 9 in non-small cell lung cancer and the underlying mechanisms. [Cell Death Discovery] |
|
|
|
| The authors integrated chromatin landscape and transcriptome analyses of patient-derived small cell lung cancer (SCLC) preclinical models to identify super-enhancers and their associated genes in the ASCL1-, NEUROD1-, and POU2F3-high SCLC subtypes. [iScience] |
| |
|
|
|
| Investigators detail adenoviral vector COVID-19 vaccines currently in human clinical trials and provide an overview of the new technologies employed in their design. [NPJ Vaccines] |
|
|
|
| Scientists discuss how molecular profiling of premalignant lesions and invasive lung squamous cell carcinoma (LUSC) has contributed to the refinement of in vitro and in vivo models, and in turn, how these systems have increased our understanding of LUSC biology and therapeutic vulnerabilities. [Communications Biology] |
|
|
|
|
| Relief Therapeutics, AG. reported that, via its newly acquired subsidiary, AdVita Lifescience GmbH, the company has been granted Orphan Drug Designation by the US FDA for RLF-100, an inhaled formulation in development for the treatment of sarcoidosis. [Relief Therapeutics, AG.] |
|
|
|
| Glenmark Pharmaceuticals, Inc. and SaNOtize Research & Development Corp. announced an exclusive long term strategic partnership to manufacture, market and distribute its breakthrough Nitric Oxide Nasal Spray for COVID-19 treatment in India and other Asian markets including Singapore, Malaysia, Hong Kong, Taiwan, Nepal, Brunei, Cambodia, Laos, Myanmar, Sri Lanka, Timor-Leste and Vietnam. [Glenmark Pharmaceuticals, Inc.] |
|
|
|
|
| September 5 – 8, 2021 Exeter, England, United Kingdom |
|
|
|
|
|
| University Hospital of Cologne – Cologne, Germany |
|
|
|
| Westwood Bioscience, Inc. – Los Angeles, California, United States |
|
|
|
| Baylor College of Medicine – Houston, Texas, United States |
|
|
|
| Johns Hopkins University – Baltimore, Maryland, United States |
|
|
|
| Stanford School of Medicine – Palo Alto, California, United States |
|
|
|
|